BioCryst Pharmaceuticals Inc (NAS:BCRX)
$ 7.82 -0.37 (-4.52%) Market Cap: 1.62 Bil Enterprise Value: 2.18 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 75/100

BioCryst Pharmaceuticals Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 11, 2021 / 01:00PM GMT
Release Date Price: $12.99 (-4.56%)
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

Good morning, everyone. My name is Gena Wang. I'm SMID Cap Biotech Analyst at Barclays. Welcome to our Second Virtual Global Healthcare Conference. First, I wish everyone to stay healthy. And I would like to thank all the participants, investors, companies and especially our event team and the corporate access team who made this virtual health care conference possible.

With that, I would like to introduce our first presenter for the day, Jon Stonehouse, Chief Executive Officer from BioCryst. Jon, I hand over for the opening remarks.

Jon P. Stonehouse
BioCryst Pharmaceuticals, Inc. - CEO, President & Director

Thank you, Gena. Let me share my screen, get it in the presentation mode. Good morning, everyone. Gena, thank you for the introduction and the invitation to your health care conference. It's great to be with you. I'd rather be with you in Miami, but virtual will do for now. So I'm going to go over a few slides in introduction, and then the rest of my team will join Gena for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot